The DOI matches its Crossref record; 294 of the 294 references it cites were found in a registry or an index.
Regulation of the p53 response and its relationship to cancer
Abstract
p53 has been studied intensively as a major tumour suppressor that detects oncogenic events in cancer cells and eliminates them through senescence (a permanent non-proliferative state) or apoptosis. Consistent with this role, p53 activity is compromised in a high proportion of all cancer types, either through mutation of the TP53 gene (encoding p53) or changes in the status of p53 modulators. p53 has additional roles, which may overlap with its tumour-suppressive capacity, in processes including the DNA damage response, metabolism, aging, stem cell differentiation and fertility. Moreover, many mutant p53 proteins, termed ‘gain-of-function’ (GOF), acquire new activities that help drive cancer aggression. p53 is regulated mainly through protein turnover and operates within a negative-feedback loop with its transcriptional target, MDM2 (murine double minute 2), an E3 ubiquitin ligase which mediates the ubiquitylation and proteasomal degradation of p53. Induction of p53 is achieved largely through uncoupling the p53–MDM2 interaction, leading to elevated p53 levels. Various stress stimuli acting on p53 (such as hyperproliferation and DNA damage) use different, but overlapping, mechanisms to achieve this. Additionally, p53 activity is regulated through critical context-specific or fine-tuning events, mediated primarily through post-translational mechanisms, particularly multi-site phosphorylation and acetylation. In the present review, I broadly examine these events, highlighting their regulatory contributions, their ability to integrate signals from cellular events towards providing most appropriate response to stress conditions and their importance for tumour suppression. These are fascinating aspects of molecular oncology that hold the key to understanding the molecular pathology of cancer and the routes by which it may be tackled therapeutically.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–294 of 294
p53: The barrier to cancer stem cell formation
Aloni-Grinstein, R., Shetzer, Y., Kaufman, T., & Rotter, V. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.02.011 · Cited by 126
Pathologies Associated with the p53 ResponsePreprint
Gudkov, A. V., & Komarova, E. A. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001180 · Cited by 126
Milne, D., Palmer, R. H., & Meek, D. W. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.21.5565 · Cited by 125
Self-citationDefective apoptosis and B-cell lymphomas in mice with p53 point mutation at Ser 23
MacPherson, D., Kim, J., Kim, T., Rhee, B. K., van Oostrom, C. T., DiTullio, R. A., Venere, M., Halazonetis, T. D., Bronson, R., de Vries, A., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600363 · Cited by 124
Phosphorylation on Thr-55 by TAF1 Mediates Degradation of p53
Li, H.-H., Li, A. G., Sheppard, H. M., & Liu, X. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00123-6 · Cited by 124
Serrano, M. A., Li, Z., Dangeti, M., Musich, P. R., Patrick, S., Roginskaya, M., Cartwright, B., & Zou, Y. (2012) · Oncogene · doi:10.1038/onc.2012.257 · Cited by 124
Puma is required for p53-induced depletion of adult stem cells
Liu, D., Ou, L. Y., Clemenson, G. D., Chao, C., Lutske, M. E., Zambetti, G. P., Gage, F. H., & Xu, Y. (2010) · Nature Cell Biology · doi:10.1038/ncb2100 · Cited by 123
Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3
LeBron, C., Chen, L., Gilkes, D. M., & Chen, J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601032 · Cited by 122
Increased Sensitivity to UV Radiation in Mice with a p53 Point Mutation at Ser389
Bruins, W., Zwart, E., Attardi, L. D., Iwakuma, T., Hoogervorst, E. M., Beems, R. B., Miranda, B., van Oostrom, C. T. M., van den Berg, J., van den Aardweg, G. J., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.20.8884-8894.2004 · Cited by 121
Shimizu, H., Burch, L. R., Smith, A. J., Dornan, D., Wallace, M., Ball, K. L., & Hupp, T. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202296200 · Cited by 120
Multiple Stress Signals Activate Mutant p53 In Vivo
Suh, Y., Post, S. M., Elizondo-Fraire, A. C., Macció, D. R., Jackson, J. G., El‐Naggar, A. K., Pelt, C. V., Terzian, T., & Lozano, G. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0459 · Cited by 120
Apoptosis in ischemic renal injury: Roles of GTP depletion and p53
Dagher, P. C. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.761_7.x · Cited by 117
Policing of oncogene activity by p53
Efeyan, A., García-Cao, I., Herranz, D., Velasco-Miguel, S., & Serrano, M. (2006) · Nature · doi:10.1038/443159a · Cited by 116
Targeted deletion of p53 prevents cardiac rupture after myocardial infarction in mice
Matsusaka, H., IDE, T., Matsushima, S., Ikeuchi, M., KUBOTA, T., Sunagawa, K., Kinugawa, S., & Tsutsui, H. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.02.001 · Cited by 111
The RP-Mdm2-p53 Pathway and Tumorigenesis
de Marval, P. L. M., & Zhang, Y. (2011) · Oncotarget · doi:10.18632/oncotarget.228 · Cited by 107
Small Molecule Inhibitors of MDM2-p53 and MDMX-p53 Interactions as New Cancer Therapeutics
Zhao, Y., Bernard, D., & Wang, S. (2013) · Biodiscovery · doi:10.7750/biodiscovery.2013.8.4 · Cited by 106
Gannon, H. S., Woda, B. A., & Jones, S. N. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.04.011 · Cited by 105
Stoichiometric Phosphorylation of Human p53 at Ser315Stimulates p53-dependent Transcription
Blaydes, J. P., Luciani, M. G., Pospíšilová, Š., Ball, H. M.-L., Vojtesek, B., & Hupp, T. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m003485200 · Cited by 104
p53 in neurodegenerative diseases and brain cancers
Checler, F., & da Costa, C. A. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.11.009 · Cited by 103
Mutation of Mouse p53 Ser23 and the Response to DNA Damage
Wu, Z., Earle, J., Saito, S., Anderson, C. W., Appella, E., & Xu, Y. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2441-2449.2002 · Cited by 103
Illuzzi, J. L., Yerkes, S., Parekh‐Olmedo, H., & Kmiec, E. B. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21881 · Cited by 101
Cox, M. L., & Meek, D. W. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.11.014 · Cited by 100
Self-citationDistinct pattern of p53 phosphorylation in human tumors
Minamoto, T., Buschmann, T., Habelhah, H., Matusevich, E., Tahara, H., Børresen‐Dale, A., Harris, C. C., Sidransky, D., & Ronai, Z. A. (2001) · Oncogene · doi:10.1038/sj.onc.1204458 · Cited by 100
West, L. E., Roy, S., Weiner, K., Hayashi, R., Shi, X., Appella, E., Kutateladze, T. G., & Gozani, O. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.139527 · Cited by 98
Solozobova, V., & Blattner, C. (2011) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v2.i9.202 · Cited by 97
Jiang, D., Brady, C. A., Johnson, T. M., Lee, E. Y., Park, E. J., Scott, M. P., & Attardi, L. D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111245108 · Cited by 95
Functional role of Mdm2 phosphorylation by ATR in attenuation of p53 nuclear export
Shinozaki, T., Nota, A., Taya, Y., & Okamoto, K. (2003) · Oncogene · doi:10.1038/sj.onc.1207176 · Cited by 93
Differential Roles of ATM- and Chk2-Mediated Phosphorylations of Hdmx in Response to DNA Damage
Pereg, Y., Lam, S., Teunisse, A., Biton, S., Meulmeester, E., Mittelman, L., Buscemi, G., Okamoto, K., Taya, Y., Shiloh, Y., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00562-06 · Cited by 93
Ullrich, S. J., Sakaguchi, K., Lees‐Miller, S. P., Fiscella, M., Mercer, W. E., Anderson, C. W., & Appella, E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.5954 · Cited by 92
Ser392 Phosphorylation Regulates the Oncogenic Function of Mutant p53
Yap, D., Hsieh, J.-K., Zhong, S., Heath, V., Gusterson, B. A., Crook, T., & Lü, X. (2004) · Cancer Research · doi:10.1158/0008-5472.can-1305-2 · Cited by 87
Regulation of MDM2 E3 Ligase Activity by Phosphorylation after DNA Damage
Cheng, Q., Cross, B. L., Li, B., Chen, L., Li, Z., & Chen, J. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05553-11 · Cited by 85
Role for 53BP1 Tudor Domain Recognition of p53 Dimethylated at Lysine 382 in DNA Damage Signaling
Kachirskaia, I., Shi, X., Yamaguchi, H., Tanoue, K., Wen, H., Wang, E. W., Appella, E., & Gozani, O. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806020200 · Cited by 84
Sürücü, B., Bozulic, L., Hynx, D., Parcellier, A., & Hemmings, B. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803053200 · Cited by 81
Cai, X., & Liu, X. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804608105 · Cited by 81
Binding of p53 to the Central Domain of Mdm2 Is Regulated by Phosphorylation
Kulikov, R., Winter, M., & Blattner, C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513311200 · Cited by 81
Inhibition of p53 DNA Binding Function by the MDM2 Protein Acidic Domain
Cross, B. L., Chen, L., Cheng, Q., Li, B., Yuan, Z.-M., & Chen, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.228981 · Cited by 80
Wang, Y. V., Leblanc, M., Wade, M., Jochemsen, A. G., & Wahl, G. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.05.008 · Cited by 79
How phosphorylation controls p53
MacLaine, N. J., & Hupp, T. R. (2011) · Cell Cycle · doi:10.4161/cc.10.6.15076 · Cited by 78
Meek, D. W., & Hupp, T. R. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2009.10.005 · Cited by 76
Self-citationDumaz, N., Milne, D., Jardine, L., & Meek, D. W. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3590459 · Cited by 75
Self-citationJenkins, L. M. M., Yamaguchi, H., Hayashi, R., Cherry, S., Tropea, J. E., Miller, M., Wlodawer, A., Appella, E., & Mazur, S. J. (2009) · Biochemistry · doi:10.1021/bi801716h · Cited by 74
Grison, A., Mantovani, F., Comel, A., Agostoni, E., Gustincich, S., Persichetti, F., & Del Sal, G. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106198108 · Cited by 73
Timed Somatic Deletion of p53 in Mice Reveals Age-Associated Differences in Tumor Progression
Hinkal, G. W., Parikh, N., & Donehower, L. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006654 · Cited by 73
Murine double minute 2: p53-independent roads lead to genome instability or death
Bouska, A. C., & Eischen, C. M. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.02.006 · Cited by 72
Chromosomal breaks during mitotic catastrophe trigger γH2AX–ATM–p53-mediated apoptosis
Imreh, G., Norberg, H. V., Imreh, S., & Zhivotovsky, B. (2011) · Journal of Cell Science · doi:10.1242/jcs.081612 · Cited by 72
Shouse, G., Cai, X., & Liu, X. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00983-07 · Cited by 72
Mutations in Proline 82 of p53 Impair Its Activation by Pin1 and Chk2 in Response to DNA Damage
Berger, M., Stahl, N., Sal, G. D., & Haupt, Y. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.13.5380-5388.2005 · Cited by 72
Extensive Post-translational Modification of Active and Inactivated Forms of Endogenous p53
DeHart, C. J., Chahal, J. S., Flint, S. J., & Perlman, D. H. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.030254 · Cited by 70
Limited Role of Murine ATM in Oncogene-Induced Senescence and p53-Dependent Tumor Suppression
Efeyan, A., Murga, M., Martínez-Pastor, B., Ortega-Molina, A., Soria, R., Collado, M., Fernández-Capetillo, Ó., & Serrano, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005475 · Cited by 70
Illuminating p53 function in cancer with genetically engineered mouse models
Garcia, P. B., & Attardi, L. D. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2013.12.014 · Cited by 69
Mutant TP53 Posttranslational Modifications: Challenges and Opportunities
Nguyen, T.-A., Menendez, D., Resnick, M. A., & Anderson, C. W. (2014) · Human Mutation · doi:10.1002/humu.22506 · Cited by 69
c-Abl Phosphorylates Hdmx and Regulates Its Interaction with p53
Zuckerman, V., Lenos, K., Popowicz, G. M., Silberman, I., Grossman, T., Marine, J.-C., Holak, T. A., Jochemsen, A. G., & Haupt, Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809211200 · Cited by 68
Mutant p53 oncogenic functions are sustained by Plk2 kinase through an autoregulatory feedback loop
Valenti, F., Fausti, F., Biagioni, F., Shay, T., Fontemaggi, G., Domany, E., Yaffe, M. B., Strano, S., Blandino, G., & Agostino, S. D. (2011) · Cell Cycle · doi:10.4161/cc.10.24.18682 · Cited by 65
Hay, T., & Meek, D. W. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01850-0 · Cited by 62
Self-citationMdm2 and MdmX as Regulators of Gene Expression
Biderman, L., Manley, J. L., & Prives, C. L. (2012) · Genes & Cancer · doi:10.1177/1947601912455331 · Cited by 61
Winter, M., Milne, D., Dias, S., Kulikov, R., Knippschild, U., Blattner, C., & Meek, D. (2004) · Biochemistry · doi:10.1021/bi0489255 · Cited by 60
Colin, D., Hain, K. O., Allan, L. A., & Clarke, P. R. (2015) · Open Biology · doi:10.1098/rsob.140156 · Cited by 55
Anderson, C. W., & Appella, E. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00264-3 · Cited by 54
Melnikova, V. O., Santamaria, A. B., Bolshakov, S. V., & Ananthaswamy, H. N. (2003) · Oncogene · doi:10.1038/sj.onc.1206595 · Cited by 53
Lee, H. S., Hauber, S., Vinduš, D., & Niemeyer, M. (2008) · Inorganic Chemistry · doi:10.1021/ic800029z · Cited by 52
Zerbini, L. F., Wang, Y., Correa, R. G., Cho, J., & Libermann, T. A. (2005) · Cell Cycle · doi:10.4161/cc.4.9.1966 · Cited by 51
p53 and TFIIEα share a common binding site on the Tfb1/p62 subunit of TFIIH
Lello, P. D., Jenkins, L. M. M., Mas, C., Langlois, C., Malitskaya, E., Fradet‐Turcotte, A., Archambault, J., Legault, P., & Omichinski, J. G. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707892105 · Cited by 51
Requirement of ATM for Rapid p53 Phosphorylation at Ser46 without Ser/Thr-Gln Sequences
Kodama, M., Otsubo, C., Hirota, T., Yokota, J., Enari, M., & Taya, Y. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00810-09 · Cited by 50
Switching on p53: an essential role for protein phosphorylation?
Loughery, J., & Meek, D. W. (2013) · Biodiscovery · doi:10.7750/biodiscovery.2013.8.1 · Cited by 49
Self-citationPosttranslational phosphorylation of mutant p53 protein in tumor development
Matsumoto, M., Furihata, M., & Ohtsuki, Y. (2006) · Medical Molecular Morphology · doi:10.1007/s00795-006-0320-0 · Cited by 47
Hjerrild, M., Milne, D., Dumaz, N., Hay, T., Issinger, O., & Meek, D. W. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3550347 · Cited by 46
Self-citationModulation of p53 C-Terminal Acetylation by mdm2, p14ARF, and Cytoplasmic SirT2
van Leeuwen, I. M. M., Higgins, M., Campbell, J., McCarthy, A. R., Sachweh, M. C. C., Navarro, A. M., & Laín, S. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0904 · Cited by 45
Hoogervorst, E. M., Bruins, W., Zwart, E., van Oostrom, C. T. M., van den Aardweg, G. J., Beems, R. B., van den Berg, J., Jacks, T., STEEG, H. V., & de Vries, A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4328 · Cited by 41
Guo, L., Liew, H. P., Camus, S., Goh, A. M., Chee, L., Lunny, D. P., Lane, E. B., & Lane, D. P. (2012) · Oncogene · doi:10.1038/onc.2012.409 · Cited by 40
Bruins, W., Bruning, O., Jonker, M. J., Zwart, E., van der Hoeven, T. V., Pennings, J. L. A., Rauwerda, H., de Vries, A., & Breit, T. M. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01610-07 · Cited by 38
Illuzzi, J. L., Vickers, C. A., & Kmiec, E. B. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9516-4 · Cited by 35
The roles of MDM2 and MDMX phosphorylation in stress signaling to p53
Chen, J. (2012) · Genes & Cancer · doi:10.1177/1947601912454733 · Cited by 33
Abnormal MDMX degradation in tumor cells due to ARF deficiency
Li, X., Gilkes, D., Li, B., Cheng, Q., Pernazza, D., Lawrence, H., Lawrence, N., & Chen, J. (2012) · Oncogene · doi:10.1038/onc.2011.534 · Cited by 32
The ARF/Oncogene Pathway Activates p53 Acetylation within the DNA Binding Domain
Mellert, H. S., Sykes, S. M., Murphy, M. E., & McMahon, S. B. (2007) · Cell Cycle · doi:10.4161/cc.6.11.4343 · Cited by 32
It Takes 15 to Tango: Making Sense of the Many Ubiquitin Ligases of p53
Love, I. M., & Grossman, S. R. (2012) · Genes & Cancer · doi:10.1177/1947601912455198 · Cited by 32
Matsumoto, M., Furihata, M., Kurabayashi, A., Sasaguri, S., Araki, K., Hayashi, H., & Ohtsuki, Y. (2004) · Oncology · doi:10.1159/000081001 · Cited by 31
ATM in focus: A damage sensor and cancer target
Khalil, H. S., Tummala, H., & Zhelev, N. (2012) · Biodiscovery · doi:10.7750/biodiscovery.2012.5.1 · Cited by 31
A Novel p53 Phosphorylation Site within the MDM2 Ubiquitination Signal
Fraser, J. A., Madhumalar, A., Blackburn, E. A., Bramham, J., Walkinshaw, M. D., Verma, C. S., & Hupp, T. R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.143107 · Cited by 29
p53 Antiproliferative Function Is Enhanced by Aspartate Substitution at Threonine 18 and Serine 20
Jabbur, J. R., & Zhang, W. D. (2002) · Cancer Biology & Therapy · doi:10.4161/cbt.81 · Cited by 28
Keeping p53 in Check: A High-Stakes Balancing Act
Berger, S. L. (2010) · Cell · doi:10.1016/j.cell.2010.06.026 · Cited by 28
A Novel p53 Phosphorylation Site within the MDM2 Ubiquitination Signal
Fraser, J. A., Vojtěšek, B., & Hupp, T. R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.143099 · Cited by 28
Brown, C. J., Srinivasan, D., Jun, L. H., Coomber, D., Verma, C. S., & Lane, D. P. (2008) · Cell Cycle · doi:10.4161/cc.7.5.5488 · Cited by 28
Bar, J. K., Saomska, I., Rabczycki, J., Noga, L., & Grybov, M. (2009) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181b70465 · Cited by 28
Furihata, M., Kurabayashl, A., Matsumoto, M., Sonobe, H., Ohtsuki, Y., Terao, N., Kuwahara, M., & Shuin, T. (2002) · The Journal of Pathology · doi:10.1002/path.1082 · Cited by 26
Phosphorylation of Ser312 contributes to tumor suppression by p53 in vivo
Slee, E. A., Benassi, B., Goldin, R. D., Zhong, S., Ratnayaka, I., Blandino, G., & Lü, X. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005165107 · Cited by 25
Autoactivation of the MDM2 E3 Ligase by Intramolecular Interaction
Cheng, Q., Song, T., Chen, L., & Chen, J. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00246-14 · Cited by 25
Campbell, H. G., Mehta, R., Neumann, A. A., Rubio‐Terres, C., Baird, M. A., Slatter, T. L., & Braithwaite, A. W. (2012) · Oncogene · doi:10.1038/onc.2012.102 · Cited by 23
Ray, D., Murphy, K. R., & Gal, S. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.20835 · Cited by 21
Checler, F., & da Costa, C. A. (2013) · Neurodegenerative Diseases · doi:10.1159/000354075 · Cited by 20
p53 isoforms change p53 paradigm
Bourdon, J. (2014) · Molecular & Cellular Oncology · doi:10.4161/23723548.2014.969136 · Cited by 19
Pan, W., Issaq, S. H., & Zhang, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021625 · Cited by 19
Lysine methylation and the regulation of p53
Carr, S. M., Munro, S., & Thangue, N. B. L. (2012) · Essays in Biochemistry · doi:10.1042/bse0520079 · Cited by 18
A spatiotemporal characterization of the effect of p53 phosphorylation on its interaction with MDM2
ElSawy, K. M., Sim, A. Y. L., Lane, D. P., Verma, C. S., & Caves, L. S. D. (2015) · Cell Cycle · doi:10.4161/15384101.2014.989043 · Cited by 14
What a Difference a Phosphate Makes: Life or Death Decided by a Single Amino Acid in MDM2
Li, Y., & Wahl, G. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.04.033 · Cited by 6
Cited by
Regulating tumor suppressor genes: post-translational modifications
Chen, L., Liu, S., & Tao, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0196-9 · Cited by 449
p53 modifications: exquisite decorations of the powerful guardian
Liu, Y., Tavana, O., & Gu, W. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz060 · Cited by 392
Autophagy as a molecular target for cancer treatment
Kocaturk, N. M., Akkoc, Y., Kig, C., Bayraktar, O., Gozuacik, D., & Kutlu, O. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.04.011 · Cited by 387
Relevance of the p53–MDM2 axis to aging
Wu, D., & Prives, C. (2018) · Cell Death & Differentiation · doi:10.1038/cdd.2017.187 · Cited by 215
Harnessing big ‘omics’ data and AI for drug discovery in hepatocellular carcinoma
Chen, B., Garmire, L., Calvisi, D. F., Chua, M.-S., Kelley, R. K., & Chen, X. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0240-9 · Cited by 154
Metadata
- Authors
- Meek, D. W.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2015-07-23
- Volume
- 469
- Issue
- 3
- Pages
- 325-346
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- OpenAlex
- W2204583106
- Cited by
- 288
- References
- 294
- FWCI
- 18.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.